NIPT Analysis platform
(Non-Invasive Prenatal Test)

Recently, pregnant women with fetuses at high risk of defects are remarkably increased due to the social and environmental risk factors’ increasing such as late marriage, pollution, and stress. Thus, chromosomal abnormalities of the fetus are also increasing. Inevitably, state-of-art technology of detection of fetal trisomy such as “Non-Invasive Prenatal Test (NIPT) of the fetal genome” is a hot global issue nowadays.

 

Thanks to the newest NGS technologies, chromosomal abnormalities are non-invasively detectable with over 99.99% confident sensitivity and specificity level. As result, NIPT is now evolving toward favorable and affordable prenatal diagnosis techniques.

While analyzing the NIPT Fetal DNA ratio is very important. We have a highly accurate technique to detect Fetal Fraction in cfDNA.

We are experienced in the NIPT and our technology is highly accurate in the field of NIPT.

for more information mail us info@genomecare.net

WHAT is

NIPT Analysis Platform?

NIPT is a screening method for detecting certain specific chromosomal abnormalities in a developing baby. After 10 weeks of pregnancy.

Genomom Software can detect whether your baby is at risk of fetal trisomy 13, 18, 21 (Patau syndrome, Edwards syndrome, and Down syndrome) and also T9, T16, T22 as well as Sex Chromosome aneuploidies accurately.

With the decreasing price of Sequencing devices, the demand for the NIPT test is increasing Globally.

Genomom Software is the best option for newcomers who want to start their own NIPT  platform.

Who need

NIPT Analysis Platform?

  • Any global organizations (Hospitals, private labs, Research Centres, Fertility Centres) that have Sequencing Machines (Thermo Fisher Platform).

  • Who has their NIPT Pipeline with low accuracy.

  • Who wants to expand business in the NIPT area.

  • Thermofisher sequencer buyer.

NIPT Analysis PROCESS

NIPT Analysis is a cost-effective platform to do NIPT analysis. Theragen GenomeCare is doing NIPT since 2015 with the Thermo Fisher sequencer.Theragen GenomeCare Published various papers in the field of NIPT  with having 4 NIPT-related Patents registered in Korea.

 

  • Sequenced the Sample in your lab with a minimum of 5000000 total Read per sample (greater than 0.1x).

  • upload the NIPT file to our server.

  • Provide basic information about the sample.

  • Data Analysis (bioinformatics)

  • Detect fetal chromosomal aneuploidy

  • Result publishing.

LIST of TEST 

in NIPT

Basic Test

  • Gender information

  • Down syndrome, Edwards syndrome, and Patau syndrome : 99% sensitivity

  • Turner syndrome, klinefelter syndrome, superfemale syndrome, jacobs syndrome : 95% sensitivity

Plus Test

  • Trisomy 22, 9 ,16

  • Micro deletions for
    1P36, Cri-du-Chat (5P), 2q33.1, Jacobsen syndrome(11q23),
    Prader-Willi /Angelman syndrome (15q11.2), DiGeorgeII
    (10p14), 16p12.2, Van der Woude syndrome(1q32.2)

810 Gwanggyo Central Biz Tower, Suwon-si, Gyeonggi-do, Republic of Korea   e-mail : info@genomecare.net

©2020 by THERAGEN GENOMECARE.

All rights reserved.